Literature DB >> 23311827

Lung function changes in older people with metabolic syndrome and diabetes.

Simone Scarlata1, Filippo Luca Fimognari, Matteo Cesari, Renato Giua, Alessandro Franco, Patrizio Pasqualetti, Ruggero Pastorelli, Raffaele Antonelli-Incalzi.   

Abstract

AIM: Restrictive lung dysfunction (RLD; defined as reduced forced vital capacity [FVC] in the presence of normal forced expiratory volume in 1 s [FEV1]/FVC ratio) is highly prevalent in the elderly, and is associated with diabetes, metabolic syndrome (MetS) and abdominal obesity. The aim of this study was to assess the relative contribution of diabetes, MetS and abdominal obesity in characterizing RLD in the elderly.
METHODS: This was cross-sectional analysis of 192 consecutive, community-dwelling persons (mean age 70.8 ± 8 years). The participants were grouped according to the number of MetS components (i.e. 0, 1, 2, 3 or 4) and the presence of diabetes. According to the Adult Treatment Panel-III criteria, participants with three or four components were considered to be affected by MetS. Independent correlates of RLD and obstructive lung dysfunction (OLD; FEV1/FVC < 0.70) were assessed by logistic regression models.
RESULTS: The mean age of the sample population was 70.8 years. FVC expressed as percent of the predicted value declined for an increasing number of MetS components (P < 0.0001), but diabetes did not account for further ventilatory decline. Consistently, MetS (OR 3.03, 95% CI 1.16-7.89) and abdominal obesity (OR 4.89, 95% CI 1.17-20.3), but not diabetes, were independently associated with RLD. OLD did not worsen for an increasing number of MetS components and was only related to age (OR 1.07, 95% CI 1.01-1.13) and smoking (OR 1.04, 95% CI 1.01-1.06).
CONCLUSIONS: MetS and abdominal obesity, two conditions of prediabetes, but not diabetes itself, are closely associated with RLD. These conditions might be implicated in the pathogenesis of the RLD, which is frequently observed in diabetic patients.
© 2013 Japan Geriatrics Society.

Entities:  

Keywords:  insulin resistance; metabolic syndrome; obstructive lung dysfunction; restrictive lung dysfunction; type 2 diabetes mellitus

Mesh:

Year:  2013        PMID: 23311827     DOI: 10.1111/ggi.12026

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  8 in total

1.  Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes.

Authors:  Hwa Mu Lee; Yanglu Zhao; Michael A Liu; David Yanez; Mercedes Carnethon; R Graham Barr; Nathan D Wong
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

Review 2.  The effect of obesity on lung function.

Authors:  Anne E Dixon; Ubong Peters
Journal:  Expert Rev Respir Med       Date:  2018-08-14       Impact factor: 3.772

3.  [Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].

Authors:  Nikolaus Buchmann; Kristina Norman; Elisabeth Steinhagen-Thiessen; Ilja Demuth; Rahel Eckardt
Journal:  Z Gerontol Geriatr       Date:  2015-10-27       Impact factor: 1.281

4.  The association between glycemic control and lung function impairment in individuals with diabetes: the Saku study.

Authors:  Nao Sonoda; Akiko Morimoto; Yukako Tatsumi; Kei Asayama; Takayoshi Ohkubo; Satoshi Izawa; Yuko Ohno
Journal:  Diabetol Int       Date:  2018-11-19

5.  Ventilatory function and cardiovascular disease risk factors: a cross-sectional study in young adults.

Authors:  Vanessa Garcia-Larsen; Patricia Bustos; Hugo Amigo; James Potts; Roberto J Rona
Journal:  BMC Pulm Med       Date:  2014-12-18       Impact factor: 3.317

6.  Rapid decline in lung function is temporally associated with greater metabolically active adiposity in a longitudinal study of healthy adults.

Authors:  Maan Moualla; Clifford Qualls; Alexander Arynchyn; Bharat Thyagarajan; Ravi Kalhan; Lewis J Smith; John J Carr; David R Jacobs; Akshay Sood
Journal:  Thorax       Date:  2017-07-20       Impact factor: 9.102

7.  The relation between insulin resistance and lung function: a cross sectional study.

Authors:  Gul Sagun; Canan Gedik; Esra Ekiz; Engin Karagoz; Mumtaz Takir; Aytekin Oguz
Journal:  BMC Pulm Med       Date:  2015-11-06       Impact factor: 3.317

8.  Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome.

Authors:  Kei Nakajima
Journal:  J Clin Med Res       Date:  2020-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.